This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

PCC 2022 — Pharmaceutical Compliance Congress

THE GAME CHANGES IN:

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as a Hybrid Event April 26 - May 4, 2022
In-Person: April 26-28 ● Virtual: May 3-4Washington, DC

Klaus Moosmayer
Member of the Executive Committee and Chief Ethics, Risk & Compliance Officer at Novartis

Profile

Klaus Moosmayer joined Novartis in 2018 as Chief Ethics, Risk & Compliance Officer. In this role, he oversees several important functions that help Novartis deliver on its strategy to build trust with society.

Today, Klaus is transforming ethics, risk and compliance at Novartis in the same way the company is reimagining medicine – by pursuing innovation, using data and digital, and unleashing the creative power of employees to embed ethics into the core of the business.

Agenda Sessions

  • Ethics, Risk and Compliance – A Holistic Assurance Concept

    11:30am